French dupilumab EAP in toddlers: Durable response or follow‐up bias?
Journal of the European Academy of Dermatology and Venereology · 2026-07 · 40 (7)
DOI: 10.1111/jdv.70401 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 07.03.2026. Verfasst von Xiaowei Zhang. Beteiligte Einrichtung: Department of Oncology, Xi'an Central Hospital, Xi'an, Shaanxi, China. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Xi'an Central Hospital, Xi'an, Shaanxi, China.
ORCID-Profile: Xiaowei Zhang
Zitieren
APA
Zhang, X. (2026). French dupilumab EAP in toddlers: Durable response or follow‐up bias?. Journal of the European Academy of Dermatology and Venereology, 40(7). https://doi.org/10.1111/jdv.70401
Vancouver
Zhang X. French dupilumab EAP in toddlers: Durable response or follow‐up bias?. Journal of the European Academy of Dermatology and Venereology. 2026;40(7). doi:10.1111/jdv.70401
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaowei},
title = {French dupilumab EAP in toddlers: Durable response or follow‐up bias?},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
volume = {40},
number = {7},
doi = {10.1111/jdv.70401}
}
EUVIMED